EIM
Essex Investment Management Portfolio holdings
AUM $550M
1-Year Return
61.92%
This Quarter Return
+10.39%
1 Year Return
+61.92%
3 Year Return
+215.25%
5 Year Return
+515.98%
10 Year Return
+2,449.6%
AUM
$716M
AUM Growth
+$28.2M
(+4.1%)
Cap. Flow
-$965K
Cap. Flow
% of AUM
-0.13%
Top 10 Holdings %
Top 10 Hldgs %
16.05%
Holding
426
New
40
Increased
110
Reduced
102
Closed
56
Top Buys
| 1 |
Primoris Services
PRIM
|
+$7.54M |
| 2 |
Xylem
XYL
|
+$5.87M |
| 3 |
Globus Medical
GMED
|
+$5.66M |
| 4 |
Select Medical
SEM
|
+$5.25M |
| 5 |
Box
BOX
|
+$5.05M |
Top Sells
| 1 |
Castle Biosciences
CSTL
|
+$10.9M |
| 2 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$8.43M |
| 3 |
VRAY
ViewRay, Inc.
VRAY
|
+$4.61M |
| 4 |
Energy Recovery
ERII
|
+$4.57M |
| 5 |
Microsoft
MSFT
|
+$3.82M |
Sector Composition
| 1 | Technology | 28.32% |
| 2 | Industrials | 24.19% |
| 3 | Healthcare | 15.92% |
| 4 | Consumer Discretionary | 7.08% |
| 5 | Materials | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Duke Energy
DUK
$93.5B
| $206K | 0.03% |
2,291
| – | – |
|
277
nVent Electric
NVT
$15.5B
| $205K | 0.03% |
3,977
| – | – |
|
278
Glaukos
GKOS
$4.72B
| $205K | 0.03% |
2,884
-10,829
| -79% | -$771K |
|
|
NVEE
279
DELISTED
NV5 Global
NVEE
| $188K | 0.03% |
6,800
| – | – |
|
|
ALTR
280
DELISTED
Altair Engineering Inc. Class A Common Stock
ALTR
| $186K | 0.03% |
2,449
-695
| -22% | -$52.7K |
|
281
Liquidity Services
LQDT
$876M
| $185K | 0.03% |
11,210
| – | – |
|
282
Abbott
ABT
$231B
| $178K | 0.02% |
1,637
| – | – |
|
283
Acuity Brands
AYI
$10.5B
| $177K | 0.02% |
1,084
| – | – |
|
284
ACM Research
ACMR
$1.99B
| $173K | 0.02% |
13,230
| – | – |
|
285
Southern Company
SO
$101B
| $169K | 0.02% |
2,400
| – | – |
|
286
Range Resources
RRC
$8.55B
| $151K | 0.02% |
5,149
| – | – |
|
287
Genpact
G
$7.2B
| $149K | 0.02% |
3,958
| – | – |
|
288
Waste Management
WM
$86.2B
| $143K | 0.02% |
827
| – | – |
|
289
Merck
MRK
$203B
| $139K | 0.02% |
1,207
-12
| -1% | -$1.39K |
|
290
Pacific Biosciences
PACB
$369M
| $139K | 0.02% |
10,459
| – | – |
|
|
ITCI
291
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $135K | 0.02% |
2,129
| – | – |
|
292
Dana Inc
DAN
$2.69B
| $134K | 0.02% |
7,866
| – | – |
|
293
SiTime
SITM
$7.51B
| $130K | 0.02% |
1,100
| – | – |
|
294
ACI Worldwide
ACIW
$5.1B
| $129K | 0.02% |
5,550
| – | – |
|
295
Nutanix
NTNX
$20.8B
| $127K | 0.02% |
4,539
| – | – |
|
296
Dow Inc
DOW
$17.4B
| $126K | 0.02% |
2,362
-19
| -0.8% | -$1.01K |
|
297
Euronet Worldwide
EEFT
$3.54B
| $124K | 0.02% |
+1,054
| New | +$124K |
|
298
Q2 Holdings
QTWO
$5.09B
| $121K | 0.02% |
3,910
| – | – |
|
299
GE Aerospace
GE
$311B
| $120K | 0.02% |
1,372
-6
| -0.4% | -$526 |
|
300
Oracle
ORCL
$871B
| $119K | 0.02% |
1,000
| – | – |
|